Psychedelic Drug Trials, Patient Safety Take Spotlight at FDA Hearing

(MedPage Today) -- The FDA gathered public feedback Monday during a 4-hour hearing about potential therapeutic use of psychedelic drugs.
Most of the hearing's 80 speakers offered strong support for psychedelic medicine, highlighting its efficacy...